University of California San Francisco
Give to UCSF<p>Matthew State, MD, PhD, a leading child psychiatrist and internationally recognized expert on the genetics and genomics of autism, Tourette syndrome and other neurodevelopmental syndromes, was recently named to lead UCSF’s psychiatric programs.</p>
UC San Francisco's Jonathan Ostrem, PhD, and David Weinberg, PhD, have been acknowledged in Forbes magazine’s “30 under 30” list for their contributions to science and healthcare.
Drugs and medical devices tend to appear more beneficial in scientific papers if they were manufactured by the company that sponsored the study, showing that who pays for the clinical trial has a direct impact on the reported outcome, according to a new analysis by researchers at UCSF and the Cochrane Collaboration.
<p>Precision medicine and cancer genetics were among the topics discussed during 11 breakout sessions guided by 30 UCSF faculty members at the Nov. 7 showcase for the UCSF Helen Diller Family Comprehensive Cancer Center.</p>
<p>The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.</p>
Five UCSF scientists – bioengineers Tejal Desai and Shuvo Roy, MD/PhD candidate Mozziyar Etemadi, microbiologist Joe DeRisi, and physician/surgeon Michael Harrison – trace their path toward five inventions that are changing the face of medicine.
People with the shortest telomeres really do have a date with the Grim Reaper, according to new data coming out of the largest and most diverse genomics, health and longevity project in the nation.
DNA sequences obtained from a handful of patients with multiple sclerosis at the UCSF Medical Center have revealed the existence of an “immune exchange” that allows the disease-causing cells to move in and out of the brain.
<p>Personalized medicine advances arising from genetic discoveries were the primary focus of wide-ranging presentations at the <a href="http://humgen.medschool.ucsf.edu/">UCSF Institute for Human Genetics</a> 2012 Symposium on Nov. 5.</p>
<p>Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.</p>
<p>Most young scientists fresh out of graduate school are content to begin a post-doctoral fellowship, working for an established faculty member. But for Christopher Allen, PhD, award-winning research in asthma meant the fast-track onto UCSF’s faculty.</p>
As Californians prepare to vote on Proposition 37, which would require labeling of food that’s been genetically modified, debate continues on the health implications of eating such foods.
Scientists at the UCSF-affiliated Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein found in nerve cells. These findings point to a potential new tactic for treating a variety of neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease).
Scientists at the UCSF-affiliated Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes — and revealing new clues as to what happens when this process goes awry.
<p>A steady stream of new apps and devices that can be synced to ever-more sophisticated mobile phones is flowing into consumers’ hands, and this technology is revolutionizing the practice of self-tracking, in which individuals measure and collect personal data to improve their heath.</p>